Sequential Nephron Blockade Best Strategy in Resistant Hypertension
Sequential nephron blockade (SNB) promotes greater reductions in blood pressure and left ventricular mass (LVM) than sequential combined renin-angiotensin system blockade (SRASB) for patients with resistant hypertension, new research suggests. This echocardiographic substudy of the PHARES trial was presented by
3 min read
